Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office said on Tuesday.
The decision came after a study involving 3,100 children aged between 5 and 11 were administered with the vaccine found it to be 90.7 per cent effecting in that age group, said the statement, citing the National Health Regulatory Authority.
None of the children involved in the study showed severe side effects, it added.
Bahrain will be supplied with doses from the manufacturer for the 5-11 age group from the start of 2022, it said.
Nepal to rebuild early-warning system on China border after deadly flood, sources say
US House passes bill to crack down on university boycotts of Israel
Kuwait air defences deal with Iranian missile, drone attacks
Spain's PM Sanchez says no evidence Morocco orchestrated Ceuta border surge
Two Palestinian teens killed in West Bank raid by Israeli settlers, army
Latest Indonesian free meal poisoning outbreaks affect 800, lawmaker says
Chinese students marooned in floods unleashed by Typhoon Saudel's rains
US and Iran exchange attacks as lull in war appears over
